Axis Bio is an independent, privately owned preclinical CRO located in purpose-built facilities on the North Coast of Northern Ireland.
Founded in late 2013 by Dr Jenny Worthington and Catherine Maguire, the company has grown organically with a strong and diverse client base across the UK, Europe, Middle East and North America.
Our mission is to provide quality, fully bespoke preclinical solutions to support clients with their early drug discovery work. We combine proven experience and a collaborative approach to build custom-designed models for every client, ultimately reducing the time, risks and costs associated with early drug development.
In support of our principles and values, we are committed to investing in employee development, nurturing their skills and talents and placing value on their contribution to the Company. We also instill in all our employees the importance of our clients’ needs and impress upon them the potential benefit that the novel therapeutics we deal with can bring to the future of human health.
Our vision is to evolve organically and sustainably, with innovation at our core, to become a leader in preclinical research services, accelerating drug development programmes and facilitating the discovery of new medicines for the benefit of human health.